Figure 3From: Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular diseaseMechanism by which excessive circulating levels of GLP-1 may lead to insulin resistance and metabolic syndrome. GLP-1, glucagon-like peptide-1.Back to article page